Furthermore, it has been reported that the expression of FOXC1 is increased in various types of cancer, including breast cancer, hepatocellular carcinoma, pancreatic and non-small cell lung cancers, and colon cancer and associated with cancer progression [28–30]. Here, FOXC1 is linked to non-small cell lung carcinoma.